Notice of Bonus Issue of New Shares and Setting of Shareholder Registry Closure Period (Record Date: December 10, 2024)

Date : 2024-11-25

Notice of New Share Issuance (Bonus Issue)

 

At the Board of Directors meeting of S-Alpha Therapeutics, Inc. held on November 25, 2024, the following resolution was made to transfer reserves to capital and issue new shares accordingly.

 

1. Amount and Source of Reserve to Be Transferred to Capital

o Amount: KRW 3,200,637,500 out of the share premium reserve of KRW 24,328,333,920 (as of September 30, 2024). 

2. Details Regarding the Issuance of New Shares

① Type and Number of Shares:

o Registered common shares: 2,512,305 shares, Registered preferred shares: 3,888,970 shares

② Total Issuance Amount: KRW 3,200,637,500

③ Par Value per Share: KRW 500 per share

④ Record Date for New Share Allocation: December 10, 2024

⑤ Method of Allocation and Treatment of Fractional Shares:

o New shares will be issued to shareholders listed in the company's shareholder register as of the record date (December 10, 2024) at a ratio of 5 new shares for every 1 existing share owned. As the allocation ratio is 1:5, no fractional shares will arise.

⑥ Dividend Start Date for New Shares: September 30, 2024

 


Notice of Record Date and Closure Period of Shareholder Registry

 

Pursuant to Article 354 of the Commercial Act and Article 16 of the Articles of Incorporation, please be informed of the suspension of transfer of shares, registration and modification or cancellation of pledges, and registration or cancellation of trust property for the purpose of new share allocation, as detailed below.


1. Record Date for New Share Allocation: December 10, 2024
2. Closure Period of Shareholder Registry: December 11, 2024 – December 17, 2024

 

November 25, 2024
S-Alpha Therapeutics, Inc.
CEO Seungeun Choi